Sanofi Strikes $140 Million Drug-Research Deal With Aqemia

French pharmaceutical technology company Aqemia has reached a multi-year research collaboration agreement valued at up to $140 million with industry giant Sanofi SA, according to a statement.

As part of the multi-year agreement, Aqemia will design novel drug molecules using its generative AI and deep physics algorithms and platform, it said in the statement. Unlike other AI-driven platform technologies that require chemical experimental data to train on before starting the design phase, Aqemia will generate such data right from the start of a project.

“This new partnership with Aqemia is part of an ongoing story that began with our ...